News

The Netherlands has today become the seventh country to ratify the ELIXIR Consortium Agreement (ECA), which provides the legal basis for ELIXIR. The Netherlands now joins the UK, Sweden, Switzerland, the Czech Republic, Estonia, Norway and EMBL in becoming full

On 13 - 16 January, the Dutch ELIXIR Node, in cooperation with the Netherlands eScience Center and the Lorentz Center, organized an ‘unconference’ entitled: ‘Jointly designing a Data FAIRPORT’. During these four days key aspects of a global infrastructure for

Partners from the EU-funded BioMedBridges cluster project have developed a joint position on the principles for data sharing across European Research Infrastructures. The document outlines the context in which data held by the Research Infrastructures involved is produced, archived, shared

Inge Jonnason (C), Head of Norwegian ELIXIR Node, with Robert-Jan Smits (L) and Finn Drablos (R) Norway is now the sixth country - and seventh member - to ratify the ELIXIR Consortium Agreement (ECA), the document providing the legal basis

Belgium becomes seventeenth country to sign ELIXIR MoU Brussels, 18 December 2013 - During the ELIXIR launch event in Brussels, Belgium announced that it had become the latest country to sign the ELIXIR Memorandum of Understanding (MoU). This takes the

The presentations given at the ELIXIR launch event on 18 December are now available below. The photos from the event are available via ELIXIR's Flickr page. The event marked the ratification of the ELIXIR Consortium Agreement and the formal launch

On 18 December 2013, ELIXIR enters its permanent phase as Estonia becomes the fifth country to ratify the ELIXIR Consortium Agreement. This marks the formal launch of the infrastructure for biological data in Europe, supporting life science research and its

The most recent edition of the Swiss State Secretariat for Education, Research and Innovation's newsletter includes an in-depth interview with Professor Ron Appel, the Executive Director of SIB Swiss Institute of Bioinformatics. SIB is the Swiss ELIXIR Node. The interview

On November 18, 2013, at the Supercomputing Conference SC13 in Denver (US), the Enlighten Your Research (EYR) Global award were announced. EYR Global aims to identify research programs that could significantly benefit from enhanced global network connectivity. One of the

Czech Republic has become the fourth country to ratify the ELIXIR Consortium Agreement (ECA), which is the document that provides the legal basis for ELIXIR. The ECA has already been ratified by the United Kingdom, Sweden, Switzerland and EMBL. ELIXIR

The Autumn 2013 edition of Informed, the ELIXIR newsletter is now available here.

ELIXIR MoU now has signature of 16 countries and EMBL Hinxton, 12 November 2013 – France has become the 16th country to sign the Memorandum of Understanding (MoU) to participate in ELIXIR, the pan-European undertaking to safeguard the results of

Switzerland’s State Secretary for Education, Research and Innovation, Dr Mauro Dell’Ambrogio, has signed the ELIXIR Consortium Agreement for the establishment of ELIXIR, the European Life science Infrastructure for Biological Information. The ELIXIR Consortium Agreement will now enter into force when

On Monday 29 October, the UK Minister for Universities and Science David Willetts, officially opened the EMBL-EBI South Building, which is the home to the ELIXIR Hub. The funding for the new building was awarded through the UK's Large Facilities

Sweden has become the second country to ratify the ELIXIR Consortium Agreement (ECA), which is the document that provides the legal basis for ELIXIR. The ECA has already been ratified by the United Kingdom and EMBL. ELIXIR will become a

ELIXIR has joined the European Technology Platform for High Performance Computing (ETP4HPC), which is a strategic body that represents most of Europe's key public and private HPC providers. Membership of the ETP4HPC will allow ELIXIR - a distributed e-Infrastructure with

The ELIXIR Consortium Agreement (ECA) has been signed by the Biotechnology and Biological Sciences Research Council (BBSRC), on behalf of the UK bioscience research community. ELIXIR is linking centres of excellence throughout the UK and Europe, and once the ECA

ConnectedDiscovery, a leading life sciences consultancy company, has been commissioned to develop an industry engagement plan for ELIXIR. Over the coming months, the ConnectedDiscovery team will be speaking to ELIXIR partners and key contacts in industry. To feed into this

The summer edition of Informed, the ELIXIR newsletter is availabe here

The slides presented at the ELIXIR Special Session at ISMB/ECCB 2013 in Berlin are available to view here.